glp 1 pen Obesity drug cuts opiate craving | Science Optical appearance and properties of

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

MaTTianXZhangBLiMWangYYangCet alLow-dose metformin targets the lysosomal AMPK pathway through PEN2

We and others previously demonstrated GDF8 and ActA are the two major ligands which mediate the muscle minimization actions of the ActRIIA/B receptors in non-obese mice and NHPs 22,28,30 , and we have further shown that dual blockade of GDF8 and ActA led to much larger increases in muscle mass than blocking either ligand individually, and that dual blockade matched the muscle growth actions of broader ActRIIA/B blockade 28 , similar to effects seen when using a dominant-negative type II receptor or pro-domains of GDF8 and activins 22,26,27

A new study reports that older adults with diabetes taking any type of GLP-1 medication may be at a heightened risk for developing neovascular age-related macular degeneration (nAMD)

Lancet 383(9918):736747 [DOI] [PMC free article] [PubMed] [Google Scholar] 18.Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A (2008) Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement

Glucagon-like Peptide-1 Improves Beta-Cell Antioxidant Capacity via Extracellular Regulated Kinases Pathway and Nrf2 Translocation